OraSure to Present at the J.P Morgan Healthcare Conference

Rhea-AI Summary

OraSure Technologies (NASDAQ: OSUR), a leading provider of point-of-need and home diagnostic tests and sample management solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver their presentation on Thursday, January 16, 2025, at 9:00 a.m. PT.

Interested parties can access both a live webcast and replay of the presentation through the 'Events and Presentations' section of OraSure's investor relations website. This significant healthcare industry event provides OraSure an opportunity to showcase its developments and strategies to investors and healthcare professionals.

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its management team will participate in the 43rd Annual J.P. Morgan Healthcare Conference. OraSure’s presentation is scheduled for Thursday, January 16, 2025 at 9:00 a.m. PT.

A live webcast and replay of the presentation will be available in the “Events and Presentations” section of OraSure’s investor relations website at https://orasure.gcs-web.com/events-and-presentations.

About OraSure Technologies, Inc. 
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com

Investor Contact:	Media Contact:
Jason Plagman	Amy Koch
VP, Investor Relations	Director, Corporate Communications
investorinfo@orasure.com	media@orasure.com

FAQ

When is OraSure Technologies (OSUR) presenting at the 2025 J.P. Morgan Healthcare Conference?

OraSure Technologies is scheduled to present at the conference on Thursday, January 16, 2025, at 9:00 a.m. Pacific Time.

How can investors watch OraSure's (OSUR) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast and replay available in the 'Events and Presentations' section of OraSure's investor relations website at https://orasure.gcs-web.com/events-and-presentations.

Which members of OraSure (OSUR) will be presenting at the 2025 J.P. Morgan Healthcare Conference?

The press release indicates that members of OraSure's management team will participate in the conference, though specific individuals are not named.

What is the significance of OraSure's (OSUR) participation in the J.P. Morgan Healthcare Conference?

The J.P. Morgan Healthcare Conference is a prestigious annual event where healthcare companies present to investors and industry professionals, providing OraSure an important platform to showcase its diagnostic tests and sample management solutions.